Tutti i datori di lavoro
argenx SE
Dettagli
About argenx SE
Argentx SE is a biotechnology company focused on transforming immunology and delivering innovative medicines for autoimmune patients. The company is known for its first-in-class neonatal Fc receptor blocker, VYVGART, which has been approved for the treatment of generalized Myasthenia Gravis (gMG) and has the potential to address various severe autoimmune diseases.
Career Opportunities
Argentx SE offers a dynamic working environment that fosters professional growth and innovation. The company values teamwork and encourages employees to be entrepreneurial and curious, contributing to a culture that aims to make a significant difference in patients' lives.
- Collaborative team culture
- Opportunities for professional development
- Commitment to innovation in healthcare
